Penn Reproductive Research Unit, 3701 Market Street, Suite 810
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT05924464
Group Preconception Care for Fertility Patients aims to translate the well-established group prenatal care model to preconception care to improve pregnancy and neonatal outcomes. In partnership with Pomelo Care (a virtual maternity care program), the investigators are conducting this study using couples at Penn Fertility Care.
This study is active but is not currently recruiting participants.
Notify MeFemale
Interventional
Not applicable
Philadelphia, Pennsylvania, 19104, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Groups of 6-10 patients to initiate biweekly virtual group care sessions on a rolling basis, with completion of enrollment and the virtual curriculum within a year.
Time frame: From enrollment to 16 weeks
Was a blood pressure measurement recorded by a clinician in Penn EMR, yes/no
Time frame: From enrollment to 16 weeks
Was a weight measurement recorded by a clinician in Penn EMR, yes/no
Time frame: From enrollment to 16 weeks
Was a hemoglobin A1c test performed if medically indicated (history of diabetes, BMI>30) or felt necessary by health care provider, yes/no
Time frame: Enrollment, 4 months, 12 months
Generalized Anxiety Disorder 7 (GAD-7) Questionnaire will be administered to both groups at enrollment, 4 months, and 12 months. The total score for the seven items ranges from 0 to 21, with 21 indicating a worse outcome
Time frame: Enrollment, 4 months, 12 months
Patient Health Questionnaire 9 (PHQ-9) will be administered to both groups at enrollment, 4 months, and 12 months. The total score for the nine items ranges from 0 to 27 where a high score indicates a worse outcome
Time frame: Enrollment, 4 months, 12 months
Fertility Related Quality of Life (FertiQOL) Questionnaire will be administered to both groups at enrollment, 4 months, and 12 months. The 36 FertiQoL items are rated according to 5 types of response scales. The total score is 100, with higher scores indicating worse fertility-related quality of life.
Time frame: From enrollment to 12 months
Count of ovarian stimulation treatments
Time frame: From enrollment to 12 months
Count of intrauterine insemination treatments
Time frame: From enrollment to 12 months
Count of in vitro fertilization treatments
Time frame: From enrollment to 12 months
This includes the number of patients who become pregnant during the study period in both groups.
Time frame: From enrollment to 12 months
This includes the time until patients become pregnant during the study period in both groups.
Time frame: Enrollment to 16 weeks
In the intervention arm only, brief questionnaires will be distributed after each virtual session to ask participants to rate their satisfaction with the session. Patients will also complete a cumulative evaluation at the conclusion of the sessions. These surveys will use a Likert scale with a higher score indicating a better experience.
Time frame: From enrollment up to 18 months
Total number of miscarriages per participants who become pregnant in either group
Time frame: Conception to delivery, approximately 9 months
This will be scored yes if any of the following are noted in the medical record: gestational hypertension (blood pressure >140/90 on 2 or more occasions at least 4 hours apart), severe preeclampsia (blood pressure >160/110 on 2 or more occasions at least 4 hours apart, or mildly elevated blood pressures with persistent headache, scotomata, platelet count <100,000/uL, liver function tests twice the upper limit of normal, or creatinine >1.1 mg/dL), HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), or eclampsia (elevated blood pressure with seizures).
Time frame: Conception to delivery, approximately 9 months
This will be scored yes if gestational diabletes is diagnosed. Gestational diabetes is diagnosed based on an abnormal 3-hour glucose tolerance test (1-hour test blood glucose >135mg/dL will be followed by a 3-hour test). Two or more abnormal values on the 3-hour test is diagnostic of gestational diabetes. Cutoffs are 95 fasting, 180 at 1 hour, 155 at 2 hours, and 140 at 3 hours.
Time frame: Conception to delivery, approximately 9 months
This includes hospital admissions during the pregnancy for any pregnancy or non-pregnancy related complications.
Time frame: At time of delivery
Preterm delivery is defined as delivery at less than 37 weeks gestational age.
Time frame: At time of delivery
In participants who become pregnant, the incidence of cesarean delivery
Time frame: From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery
Infant admission to neonatal intensive care unit.
Time frame: From date of conception to delivery date, approximately 9 months
Total number of any presentation to the Perinatal Evaluation Center or emergency room during pregnancy
Time frame: From date of delivery to date of discharge from hospital postpartum, up to six weeks from delivery
Length of stay from birth to discharge, measured in hours
Time frame: Between 2 to 6 weeks after delivery
Edinburgh Postnatal Depression Scale will either be abstracted from the medical record, or if not administered clinically, will be administered by the study team. The total score for the ten items ranges from 0 to 30 with a higher score indicating a worse outcome.
University of Pennsylvania
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06481319
Genital Diseases, Infertility
Boston, Massachusetts, United States
View Trial DetailsNCT04549116
Genital Diseases, Infertility
Tempe, Arizona, United States
View Trial DetailsNCT07062237
Genital Diseases, Infertility
Farmington, Connecticut, United States
View Trial DetailsNCT04381299
Adnexal Diseases, Anti-Mullerian Hormone Deficiency
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
View Trial Details